Literature DB >> 31702393

LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration.

Zhi Feng1, Xu Li1, Minglian Qiu1, Ronggang Luo1, Jianbo Lin1, Bo Liu1.   

Abstract

Background: EGFR-AS1 has been characterized as an oncogenic lncRNA in many types of cancers, while its roles in esophageal squamous cell carcinoma (ESCC) are unknown.
Results: Their data showed that EGFR-AS1 and ROCK1 were upregulated in ESCC and positively correlated. Survival analysis showed that high EGFR-AS1 and ROCK1 expression levels predicted poor survival. In ESCC cells, EGFR-AS1 overexpression led to upregulated ROCK1, while miR-145 overexpression led to downregulated ROCK1 and reduced effects of EGFR-AS1 overexpression. Bioinformatics analysis showed that miR-145 may bind EGFR-AS1, while overexpression of EGFR-AS1 and miR-145 did not significantly affect each other. In esophageal squamous cell carcinoma (ESCC) cells, EGFR-AS1 and ROCK1 overexpression mediated the increased rates of ECSS cell invasion and migration. Overexpression of miR-145 played an opposite role and attenuated the effects of EGFR-AS1 overexpression.
Conclusion: Therefore, EGFR-AS1 may upregulate ROCK1 by sponging miR-145 to promote ESCC cell invasion and migration.

Entities:  

Keywords:  EGFR-AS1; ROCK1; esophageal squamous cell carcinoma; miR-145; survival

Year:  2019        PMID: 31702393     DOI: 10.1089/cbr.2019.2926

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  10 in total

1.  Long non-coding RNA BLACAT1 expedites osteosarcoma cell proliferation, migration and invasion via up-regulating SOX12 through miR-608.

Authors:  Xiaotao Chen; Yubao Cui; Yanming Ma
Journal:  J Bone Oncol       Date:  2020-08-02       Impact factor: 4.072

2.  ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.

Authors:  Ting Xin; Wei Lv; Dongmei Liu; Yongle Jing; Fang Hu
Journal:  Aging (Albany NY)       Date:  2020-06-17       Impact factor: 5.682

3.  Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458/PBX3.

Authors:  Dawei Wang; Dong You; Yinghua Pan; Peiji Liu
Journal:  Thorac Cancer       Date:  2020-05-25       Impact factor: 3.500

4.  Genetic variant rs10251977 (G>A) in EGFR-AS1 modulates the expression of EGFR isoforms A and D.

Authors:  Shankar Dhamodharan; Mathew Maria Rose; Sundaram Reddy Chakkarappan; Karuppiah Vijayamuthuramalingam Umadharshini; Ramalingam Arulmurugan; Shanmugam Subbiah; Ituro Inoue; Arasambattu Kannan Munirajan
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

5.  Testis developmental related gene 1 promotes non-small-cell lung cancer through the microRNA-214-5p/Krüppel-like factor 5 axis.

Authors:  Xudong Lu; Nian Zhao; Guangjun Duan; Zhiyong Deng; Yimin Lu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 6.  Regulation of ROCK1/2 by long non-coding RNAs and circular RNAs in different cancer types.

Authors:  Ammad Ahmad Farooqi; Rabbia Zahid; Humaira Naureen; Rukset Attar; Maria Gazouli; Rossana Berardi; Jolanta Szelachowska; Rafał Matkowski; Edyta Pawlak
Journal:  Oncol Lett       Date:  2022-03-22       Impact factor: 2.967

7.  Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1.

Authors:  Wenhui Yang; Lina Wu; Mingming Jin
Journal:  J Clin Lab Anal       Date:  2022-02-25       Impact factor: 2.352

Review 8.  A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response.

Authors:  Uttam Sharma; Masang Murmu; Tushar Singh Barwal; Hardeep Singh Tuli; Manju Jain; Hridayesh Prakash; Tea Kaceli; Aklank Jain; Anupam Bishayee
Journal:  Curr Oncol       Date:  2022-03-26       Impact factor: 3.109

Review 9.  Implication of non-coding RNA-mediated ROCK1 regulation in various diseases.

Authors:  Soudeh Ghafouri-Fard; Yadollah Poornajaf; Bashdar Mahmud Hussen; Atefe Abak; Hamed Shoorei; Mohammad Taheri; Guive Sharifi
Journal:  Front Mol Biosci       Date:  2022-09-13

Review 10.  ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.

Authors:  Tadeu L Montagnoli; Jaqueline S da Silva; Susumu Z Sudo; Aimeé D Santos; Gabriel F Gomide; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2021-06-30       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.